(Q26853709)

W. Van Biesen

series ordinal

2

1 reference

R. Vanholder

series ordinal

3

1 reference

language of work or name

1 reference

November 2012

1 reference

Nephrology Dialysis Transplantation

published in

1 reference

volume

27

1 reference

issue

11

1 reference

page(s)

4003-10

1 reference

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Hypomagnesemia in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Chronic kidney disease: effects on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Biomarkers of inflammation and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Expression of the nuclear factor-kappaB and proto-oncogenes c-fos and c-jun are induced by low extracellular Mg2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis, and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Endothelial cells and magnesium: implications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

The nerve-heart connection in the pro-oxidant response to Mg-deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Magnesium deficiency produces insulin resistance and increased thromboxane synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Aldosterone, a vasculotoxic agent--novel functions for an old hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Aldosterone receptor antagonists: effective but often forgotten

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Cardiac fibrogenesis in magnesium deficiency: a role for circulating angiotensin II and aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Spironolactone Reduced Arrhythmia and Maintained Magnesium Homeostasis in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

A long-term moderate magnesium-deficient diet aggravates cardiovascular risks associated with aging and increases mortality in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Serum magnesium, ambulatory blood pressure, and carotid artery alteration: the Ohasama study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Serum magnesium level and arterial calcification in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Low serum magnesium concentrations predict cardiovascular and all-cause mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Low serum magnesium predicts neurological events in patients with advanced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Magnesium dietary intake modulates blood lipid levels and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Vascular Smooth Muscle Cell Differentiation to an Osteogenic Phenotype Involves TRPM7 Modulation by Magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS126